Institutional
July 27, 2017
São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending
Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial Court understood in a decision on the merits the owner of pending patent applications does not enjoy exclusive rights. The decision may be subject to an appeal.
Click on Download to access the full text of the decision.
Back
Share:
Last related news
November 18, 2024
Kasznar Leonardos takes part in the operation “Black Beard” in São Paulo
The Anti-Piracy and Brand Protection team of Kasznar Leonardos supported a major operation led by the Brazilian Federal Revenue Service, targeting the … Kasznar Leonardos takes part in the operation “Black Beard” in São Paulo
November 13, 2024
Elisabeth Kasznar is the author of the book review published in The Trademark Reporter
Our partner Elisabeth Kasznar Fekete is the author of the book review Research Handbook on Design Law, published in The Trademark Reporter … Elisabeth Kasznar is the author of the book review published in The Trademark Reporter
November 4, 2024
Three partners have been recognized as Leading Partners by Legal 500
We are honored to announce that our partners Elisabeth Kasznar Fekete, Gabriel Leonardos, and Rafael Lacaz Amaral have been recognized as Leading … Three partners have been recognized as Leading Partners by Legal 500